Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the “frenzy” of weight loss drugs.

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Ahead of a Senate health committee hearing next week with Novo Nordisk CEO Lars Jørgensen, Sen. Bernie Sanders claims he has ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Rhythm Pharmaceuticals (RYTM) stock gains as JMP Securities issues a positive view on the company citing its lead product ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6-11, according to research presented Sept. 10 at a medical conference and published in the New England ...